Stockreport

Spherix Inc. Announces Definitive Terms Reached to Acquire Controlling Interest in Hoth Therapeutics, a Biopharmaceutical Company Developing its BioLexa Platform to Treat Skin Illness Such...

SPHERIX  (SPEX) 
US:NASDAQ Investor Relations: spherix.com/investors.php
PDF NEW YORK, June 20, 2017 /PRNewswire/ -- Spherix Incorporated (NASDAQ: SPEX) announced today that the Company has negotiated definitive terms to acqui [Read more]